Skip to main content
. 2021 Oct 28;13(11):1803. doi: 10.3390/pharmaceutics13111803
α-TOS α-tocopherol succinate
2D Two-Dimensional
3D Three-dimensional
5-FU 5-fluorouracil
ABX Abraxane
ADR Adverse drug reaction
ATP Adenosine triphosphate
AuNPs Gold nanoparticles
BSA Bovine serum albumin
CAT Catalase
CaP Calcium phosphate
CD-siRNA Cell death-siRNA
CDT Chemodynamic therapy
CIS Cisplatin
CS Chitosan
CT Computed tomography
CTX Chemotherapy
Cur Curcumin
CuS Copper sulfide
CMC Carboxymethyl-cellulose
DACH Oxaliplatin
DDSs Drug delivery systems
DNA Deoxyribonucleic Acid
DOX Doxorubicin
EE Encapsulation efficiency
EPR Enhanced permeability and retention
F-CDs Folate-carbon dots
FA Folic acid
FDA Food and Drug Administration
Fe Ferrous
G Graphene
Gal Galactose
GNRs Gold nanorods
H2O2 Hydrogen peroxide
HA Hyaluronic acid
ICG Indocyanine green
IM Imatinib mesylate
LA α-lipoic acid
LC Loading capacity
LDHs Layered double hydroxides
M Million
MDR Multiple drug resistance
Mel Melanin
MET Metformin
MRI Magnetic resonance imaging
MTX Methotrexate
NIR Near-infrared
NSs Nanosheets
O2 Oxygen
PAMAM Poly(amidoamine)
PC Phosphatidylcholine
PC Prostate cancer
PDA Polydopamine
PDT Photodynamic therapy
PEG Polyethylene glycol
PEI Polyethylenimine
PEITC Phenethyl isothiocyanate
Pgp P-glycoprotein
PDA Polydopamine
PLGA Poly(lactic-co-glycolic acid)
PLL Poly-L-lysine
PTT Photothermal therapy
QSAR Quantitative-structural activity relationship
R&D Research and development
RBC Red blood cells
ROS Reactive oxygen species
RV Resveratrol
SLOT Survive locate operate and terminate
SPIONs Superparamagnetic iron oxide nanoparticles
TCS Thiolated chitosan
TGI Tumor growth inhibition
TIR Tumor inhibition rate
TMDCs Transition metal dichalcogenides
TME Tumor Microenvironment
US United States
UV Ultraviolet
wt Weight